Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
CALL
Genius Sports
GENI
$2.33B
| $3.52M | ﹤0.01% |
407,400
+222,500
| +120% | +$1.86M |
|
4527
PUT
Neurocrine Biosciences
NBIX
$15.5B
| $3.52M | ﹤0.01% |
25,800
-21,700
| -46% | -$2.68M |
|
4528
Inspire 500 ETF
PTL
$907M
| $3.51M | ﹤0.01% |
+16,477
| New | +$3.59M |
|
4529
CALL
Trimble
TRMB
$13.4B
| $3.51M | ﹤0.01% |
49,700
-83,800
| -63% | -$5.7M |
|
4530
CALL
RenaissanceRe
RNR
$13.4B
| $3.51M | ﹤0.01% |
14,100
-21,900
| -61% | -$5.88M |
|
|
ABX
4531
Abacus Global Management
ABX
$907M
| $3.51M | ﹤0.01% |
448,014
+436,698
| +3,859% | +$3.74M |
|
4532
Public Service Enterprise Group
PEG
$37.9B
| $3.51M | ﹤0.01% |
41,518
+26,841
| +183% | +$2.38M |
|
|
DOG
4533
ProShares Short Dow30
DOG
$87.3M
| $3.51M | ﹤0.01% |
132,117
+127,821
| +2,975% | +$3.37M |
|
4534
PUT
ICICI Bank
IBN
$107B
| $3.51M | ﹤0.01% |
117,400
+82,500
| +236% | +$2.49M |
|
4535
US Treasury 5 Year Note ETF
UFIV
$30.7M
| $3.5M | ﹤0.01% |
73,272
+38,767
| +112% | +$1.88M |
|
4536
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$430M
| $3.5M | ﹤0.01% |
50,758
+37,120
| +272% | +$2.63M |
|
4537
iShares Core US REIT ETF
USRT
$4.64B
| $3.5M | ﹤0.01% |
61,055
+57,398
| +1,570% | +$3.45M |
|
4538
Sonoco
SON
$5.76B
| $3.5M | ﹤0.01% |
71,604
+41,346
| +137% | +$2.14M |
|
4539
CALL
PagerDuty
PD
$918M
| $3.5M | ﹤0.01% |
191,500
+54,200
| +39% | +$1.04M |
|
4540
CALL
FuelCell Energy
FCEL
$1.79B
| $3.49M | ﹤0.01% |
386,532
+365,319
| +1,722% | +$3.62M |
|
4541
CALL
ADMA Biologics
ADMA
$2.12B
| $3.49M | ﹤0.01% |
203,700
-6,500
| -3% | -$122K |
|
4542
LendingTree
TREE
$458M
| $3.49M | ﹤0.01% |
90,139
+49,217
| +120% | +$2.36M |
|
4543
State Street SPDR S&P Global Infrastructure ETF
GII
$931M
| $3.49M | ﹤0.01% |
+59,014
| New | +$3.62M |
|
4544
Capitol Federal Financial
CFFN
$1.08B
| $3.49M | ﹤0.01% |
590,719
+147,033
| +33% | +$937K |
|
|
SLNZ
4545
TCW Senior Loan ETF
SLNZ
$222M
| $3.49M | ﹤0.01% |
+73,737
| New | +$3.5M |
|
4546
CALL
Liberty Energy
LBRT
$3.59B
| $3.49M | ﹤0.01% |
175,500
+99,100
| +130% | +$1.83M |
|
4547
Peapack-Gladstone Financial
PGC
$828M
| $3.49M | ﹤0.01% |
108,911
+65,361
| +150% | +$2.17M |
|
4548
Delcath Systems
DCTH
$581M
| $3.49M | ﹤0.01% |
289,601
+135,640
| +88% | +$1.43M |
|
4549
CALL
Brookfield Renewable
BEPC
$6.59B
| $3.49M | ﹤0.01% |
126,000
+63,200
| +101% | +$1.94M |
|
4550
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
$1.04B
| $3.48M | ﹤0.01% |
77,724
+72,362
| +1,350% | +$3.35M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.